Youcare Pharmaceutical Group, founded in 2001, headquartered in Beijing and listed in 2020 (Stock Code: 688658SH), is a large-scale conglomerate integrating the new drug R&D, pharmaceutical manufacture, distribution & sales as well as international business.
With “Products, Production capacity and Productive industry chain” as the core, Youcare raised its own pharmaceutical R&D institute in Beijing, and it built a series of preparation production bases in the center cities of Beijing, Guangzhou and Hefei, on the basis of the API production bases in Anhui and Henan province.
For now, there are over 200 drug products of multiple strengths in the whole group, covering cardio-cerebrovascular, gastrointestinal system, anti-infection, endocrinology anti-tumour and other therapeutic areas. In terms of manufacture and quality management, Youcare keeps promoting technical innovation and performs intelligent manufacture and green production, to align its quality system with the heading pharmaceutical manufacturer internationally.
Starting with a global perspective, Youcare takes initiative in exploring the market for pharmaceutical imports and exports and building business association with international pharmaceutical companies. Currently, Youcare have engaged with numerous steadfast, enduring, prominent business partners from Italy, France, Germany, Japan, Korea, India, Pakistan, Uzbekistan, Chile and more than 40 countries or regions.
Innovative drugs focusing on core indications such as cardiovascular, oncology, and infectious diseases
Innovative drugs focusing on nucleic acids, peptides, cell therapies,small molecule drugs, and Innovative TCMs.